Donald Notman
Vermögen: 2 Mio $ am 30.06.2026
Vermögen: 2 Mio $ am 30.06.2026
Donald Notman is Chief Operating Officer at Ocular Therapeutix, Inc. since 2026.
Formerly, Mr. Notman was Managing Director & Head-Private Capital Markets at Leerink Partners LLC.
From 2014 to 2017, Mr. Notman was Chief Financial Officer & Senior Vice President at Thrasos Therapeutics, Inc. Education includes an undergraduate degree from Middlebury College and an MBA from Tuck School of Business at Dartmouth.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 184’662 ( 0.09% ) | 2 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Geschäftsführer | 29.08.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotheraputics for the treatment and prevention of kidney diseases | Finanzdirektor/CFO | 01.03.2017 |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Middlebury College
Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tuck School of Business at Dartmouth
Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotheraputics for the treatment and prevention of kidney diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen